Unum Group (UNM) Stock AnalysisUNMUnum Group

Unum Group is a provider of financial protection benefits in the United States and the United Kingdom. The Company offers disability, life, accident, critical illness, dental and vision, and other related services. Its segments include Unum US, Unum International, and Colonial Life. The Unum US segment comprises group disability, group life and accidental death and dismemberment, and supplemental and voluntary lines of business. It includes long-term and short-term disability, medical stop-loss, and fee-based service products. The Unum International segment includes insurance for group long-term disability, group life, and supplemental lines of business which include dental, individual disability, and critical illness products. The Colonial Life segment includes the accident, sickness, and disability product line, life product line, and cancer and critical illness product line. Its products are marketed to employees, on both a group and an individual basis. It operates in the Financials sector (ACCIDENT & HEALTH INSURANCE industry).

Unum Group is currently a hold. The stock is priced at $90.28, which is below the average analyst target of $92 to $109, indicating potential upside. However, the RSI is at 32.944, suggesting it is oversold, and the recent earnings guidance has been cautious, with a full-year EPS estimate of $8.60 to $8.90, which is below market expectations. The main risk is the cautious full-year guidance, which may impact investor confidence.

13 analysts cover UNM: 3 rate it Buy, 7 Hold and 3 Sell. The average price target is 94.00.